Fas mRNA expression in blood is reduced during episodes of human corneal graft rejection

Transplantation

Volumn 71, Issue 5, 2001, Pages 702-705

  Dixon, Janet A ^a   Reynolds, Irena ^a   Zeggini, Eleftheria ^a   Tullo, Andrew B ^a   Chantal Hillarby, M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; FAS ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; GENE AMPLIFICATION; GRAFT REJECTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

EID: 0035868367     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200103150-00024     Document Type: Article

References (10)

1. How successful is corneal transplantation - A report from the Australian corneal graft register
2. Fas ligand-induced apoptosis as a mechanism of immune privilege
3. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival
4. Increased apoptosis of T cell subsets in aging humans: Altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax
5. The immunology of corneal graft rejection
6. Identification of alphamelanocyte stimulating hormone as a potential immunosuppressive factor in aqueous-humor
7. Depletion of donor-derived Langerhans cells promotes corneal allograft survival
8. Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus
9. Glucocorticoids and cyclosporine induce apoptosis in mitogen-activated human peripheral mononuclear cells
10. Infiltrating inflammatory cell phenotypes and apoptosis in rejected human corneal allografts